GSK halts camlipixant development for chronic cough after mixed results

Go back to GSK halts camlipixant development for chronic cough after mixed results

Form 6-K GSK plc For: Jul 17

July 17, 2026 6:50 AM EDT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.... More